![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 08, 2023 5:11:11 PM
Thrilled to announce the start of an investigator initiated study evaluating our FDA cleared device for its ability to also reduce pain in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA). Stanford University initiated a study entitled "Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis" (ClinicalTrials.gov Identifier: NCT05315297) Osteoarthritis is the second-most common musculoskeletal disorder, leading to pain and functional limitations with a high social and economic burden. OA can affect every joint in the body, but it is most common in the knee, hip, spine, and hand. Within the hand, the thumb base is the most affected single joint. (https://lnkd.in/e-jPdpqF) #clinicaltrial #osteoarthritis #painrelief #painmanagement #drugfreetreatment #stanforduniversity #research $BIEL
pknopick@eandecommunications.com
6/8/2023 4:20:57 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM